BioCentury
ARTICLE | Financial News

Affimed proposes follow-on

May 4, 2015 7:00 AM UTC

Affimed N.V. (NASDAQ:AFMD), Heidelberg, Germany Business: Cancer, Inflammation, Antibodies Date announced: 2015-04-27 Type: Follow-on To be raised: Up to $40.3 million Shares: TBD Price prior: $11.72 ...